Roland Fischer

Author PubWeight™ 36.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev 2015 2.11
2 A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol 2007 1.77
3 Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease. Am J Hematol 2009 1.48
4 Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. Haematologica 2008 1.26
5 Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer 2007 1.17
6 A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 2009 1.17
7 A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia. Haematologica 2006 1.13
8 Non-transferrin-bound iron in plasma following administration of oral iron drugs. Biometals 2007 1.12
9 Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol 2005 1.00
10 Does liver biopsy overestimate liver iron concentration? Blood 2006 0.95
11 Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility. Lancet 2003 0.92
12 Erythrocytapheresis: Do Not Forget a Useful Therapy! Transfus Med Hemother 2008 0.92
13 Non-invasive liver iron quantification by SQUID-biosusceptometry and serum ferritin iron as new diagnostic parameters in hereditary hemochromatosis. Blood Cells Mol Dis 2003 0.91
14 Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry 2010 0.90
15 Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate. World J Biol Psychiatry 2010 0.88
16 Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol 2008 0.88
17 Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia. Magn Reson Imaging 2010 0.87
18 Italian Society of Hematology guidelines for thalassemia and non-invasive iron measurements. Haematologica 2008 0.86
19 Open, cyclic, and bicyclic compounds of double silylated phosphorus and boron. Dalton Trans 2004 0.85
20 Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer 2008 0.85
21 Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major. Ann N Y Acad Sci 2005 0.85
22 Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet(®) retard and Concerta(®)--a randomized, controlled, double-blind multicenter clinical crossover trial. J Child Adolesc Psychopharmacol 2011 0.84
23 DWI of the brain: postmortal DWI of the brain in comparison with in vivo data. Forensic Sci Int 2012 0.84
24 Cardiac MRI of the fetal heart using a novel triggering method: initial results in an animal model. J Magn Reson Imaging 2012 0.83
25 Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients. Br J Haematol 2014 0.81
26 Bioavailability of oral iron drugs as judged by a 59Fe-whole-body counting technique in patients with iron deficiency anaemia. Therapeutic efficacy of iron(II)-glycine sulfate. Arzneimittelforschung 2005 0.81
27 Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases. Br J Haematol 2003 0.81
28 Bioavailability of chromium(III)-supplements in rats and humans. Biometals 2012 0.80
29 Publication trends of shared decision making in 15 high impact medical journals: a full-text review with bibliometric analysis. BMC Med Inform Decis Mak 2014 0.78
30 Synthesis and properties of new phosphorescent red light-excitable platinum(II) and palladium(II) complexes with Schiff bases for oxygen sensing and triplet-triplet annihilation-based upconversion. Inorg Chem 2012 0.77
31 Effects of switching to once-daily modified-release methylphenidate from previous treatment with other psychostimulants in children and adolescents with ADHD: an observational study with clinician, parent, and teacher evaluations. J Clin Psychopharmacol 2014 0.77
32 Distribution of cardiac iron measured by magnetic resonance imaging (MRI)-R*2. J Magn Reson Imaging 2010 0.77
33 Absorption, excretion and retention of 51Cr from labelled Cr-(III)-picolinate in rats. Biometals 2008 0.77
34 BOLD MRI in the brain of fetal sheep at 3T during experimental hypoxia. J Magn Reson Imaging 2013 0.77
35 A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia. Ann N Y Acad Sci 2005 0.76
36 Pancreatic exocrine function and cardiac iron in patients with iron overload and with thalassemia. Pediatr Blood Cancer 2011 0.76
37 Does liver biopsy overestimate liver iron concentration? Blood 2006 0.76
38 A non-interventional study of extended-release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment. Atten Defic Hyperact Disord 2013 0.76
39 Synthesis and Properties of Bridgehead-Functionalized Permethylbicyclo[2.2.2]octasilanes. Organometallics 2013 0.75
40 Fetal blood flow velocimetry by phase-contrast MRI using a new triggering method and comparison with Doppler ultrasound in a sheep model: a pilot study. MAGMA 2013 0.75
41 Synthesis and characterisation of zirconium-amido guanidinato complex: a potential precursor for ZrO2 thin films. Dalton Trans 2007 0.75
42 Quantification of prenatal liver and spleen iron in a sheep model and assessment of iron stores in a human neonate with neonatal hemochromatosis using R2* mapping. Magn Reson Med Sci 2014 0.75
43 Long-term treatment with deferiprone in a L1 veteran. Eur J Haematol 2005 0.75
44 Covalent immobilisation of protease and laccase substrates onto siloxanes. Chemosphere 2010 0.75
45 Selective synthesis and derivatization of alkali metal silanides MSi(SiH3)3. Chemistry 2012 0.75
46 Stimulated resonance Raman scattering and laser oscillation in highly emissive distyrylbenzene-based molecular crystals. Adv Mater 2012 0.75
47 Peak Filling Rates Assessed by CMR Imaging Indicate Diastolic Dysfunction From Myocardial Iron Toxicity. JACC Cardiovasc Imaging 2016 0.75
48 What can actigraphy add to the concept of labschool design in clinical trials? Curr Pharm Des 2010 0.75
49 Partial halogenation of cyclic and branched perhydropentasilanes. Inorg Chem 2012 0.75